Zolpidem-Associated Consequences: An Updated Literature Review With Case Reports
- PMID: 31834190
- DOI: 10.1097/NMD.0000000000001074
Zolpidem-Associated Consequences: An Updated Literature Review With Case Reports
Abstract
A post-2000 literature search reviewed prevalence of health consequences associated with zolpidem, plus two salient case reports. Common zolpidem-related harms encompassed accidents, falls, overdoses, delirium, and infections. Risks to others included assaults, vehicular accidents, various crimes, and civil actions that occurred during zolpidem-induced delirium, withdrawal, and other impediments. Remarkably, much harm occurred while patients were taking therapeutic doses of licitly prescribed zolpidem (10-30 mg). Zolpidem-associated health, behavioral, and social problems comprise an international pandemic of preventable heath misfortunes.
References
-
- Amerio A, Gálvez JF, Odone A, Dalley SA, Ghaemi SN (2015) Carcinogenicity of psychotropic drugs: A systemic review of US Food and Drug Administration-required preclinical in vivo studies. Aust N Z J Psychiatry. 49:686–696.
-
- Bertisch SM, Herzig SJ, Winkelman JW, Buettner C (2014) National use of prescription medications for insomnia: NHANES 1999–2010. Sleep. 37:343–349.
-
- Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, Klassen TP, Witmans M (2007) The efficacy and safety of drug treatments for chronic insomnia in adults: A meta-analysis of RCT's. J Gen Intern Med. 22:1335–1350.
-
- Crestani F, Martin JR, Möhler H, Rudolph U (2000) Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol. 131:1251–1254.
-
- Daley C, McNiel DE, Binder RL (2011) "I did what?" Zolpidem and the courts. J Am Acad Psychiatry Law. 39:535–542.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
